LABD is an inverse 3x leveraged ETF tracking -300% of the daily performance of the S&P Biotechnology Select Industry Index. This tool is typically deployed for precise sectoral shorting when tightening pharmaceutical regulations or sharply rising macro interest rates place severe valuation pressure on growth-stage biotech companies.